Faculty

Course Directors & Co-Chair

Liver Scientific Committee

Becky Taub, MD

Madrigal Pharmaceuticals

Belle Vivica van Rosmalen, MD

Eli Lilly Pharmaceutical

Brian P. Lee, MD

USC Keck School of Medicine

Gene Im, MD

Columbia University

Jane Hsiao, PhD

OPKO

Scott Friedman, MD

Mount Sinai Institute for Liver Research

Jörn Schattenberg, MD

Saarland University Medical Center

Juan Pablo Arab, MD

Virginia Commonwealth University School of Medicine

Kitty Yale

Akero Therapeutics Biopharmaceutical

Lily Dara, MD

USC Keck School of Medicine

Mary Rinella, MD

University of Chicago

Meena Bansal, MD

Icahn School of Medicine at Mount Sinai

Naga Chalasani, MD

Indiana University School of Medicine

Nikhil Vergis, MD

GSK Biopharmaceutical

Norah Terrault, MD

USC Keck School of Medicine

Raj Vuppalanchi, MD

Indiana University School of Medicine

Ramy Younes, MD

Boehringer Ingelheim Pharmaceutical

Rashmee Patil, MD

Pinnacle Clinical Research

Obesity Scientific Board Committee

Carel le Roux, MBChB, PhD

University College Dublin

Ildiko Lingvay, MD, MPH, MSCS

University of Texas, Southwestern Medical Center at Dallas, TX

Domenica Rubino, MD

Washington Center for Weight Management and Research

Layla AbuShamat, MD

Baylor College of Medicine

Abd Tahrani, MD, PhD

University of Birmingham (UK)

Isabel Kloer, MD, MSc

Boehringer Ingelheim International GmbH, Ingelheim, Germany

Julia Dunn, MD, MSc, DABOM

Eli Lilly and Company

Georgios Dimitriadis, MD, MSc, PhD, FRCP

Eli Lilly and Company

Connecting liver, obesity, and metabolic science to improve patient care.

This conference looks at the bigger picture—how liver disease, obesity, and metabolic dysfunction intertwine. It creates a space where clinicians, researchers, and industry experts can break silos, share insights, and shape the future of care together. By weaving cutting-edge science with real-world clinical strategies, it challenges participants to rethink how breakthroughs move from the lab to the patient.